EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Probiotic, Prebiotic, or Synbiotic Supplementation in Parkinson’s Disease: A Systematic Review and Meta-Analysis with Trial Sequential Analysis

Miguel Cabanillas-Lazo, Milagros Pascual-Guevara, Fabian A Chavez-Ecos, Carlos Alva-Diaz, Victor Velasquez-Rimachi, Nicanor Mori, Federico Micheli

Gerontology · 09.01.2026 · 72 (2) · 126-141

DOI: 10.1159/000547665 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Gerontology, online erschienen am 09.01.2026. Verfasst von Miguel Cabanillas-Lazo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Grupo de Investigación Neurociencia, Metabolismo, Efectividad Clínica y Salud Pública (NEMECS), Universidad Científica del Sur, Lima, Peru. Hauptthemen laut MEDLINE: Parkinson Disease, Synbiotics, Prebiotics, Probiotics. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 81 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Alterations in gut microbiota have been linked to various neurological diseases, including Parkinson’s disease (PD). Modifying the microbiota through probiotics, prebiotics, or synbiotics may help improve symptoms in PD patients. This study aimed to evaluate the efficacy and safety of these supplements in treating PD.

Methods

A systematic search was conducted in several databases, including PubMed, EMBASE, Scopus, Cochrane Library, Web of Science, and Google Scholar, until September 2023. No restrictions were placed on language or publication date. Study quality was assessed, and data were analyzed using meta-analysis techniques and narrative synthesis tables. The certainty of evidence was evaluated using GRADE, and trial sequential analysis was performed for primary outcomes.

Results

Out of 3,608 studies identified, 69 were selected for review, with 16 analyzed qualitatively. Among these, 12 were randomized controlled trials, and 9 were included in the meta-analysis. Compared with the placebo group, the intervention group would improve non-motor symptoms related to constipation (weekly stools [MD]: 1.04; 95% CI: 0.83, 1.25; Bristol scale [MD]: 0.54; 95% CI: 0.38, 0.70; frequency of laxative use [MD]: −0.63; 95% CI: −0.94, −0.33) and could improve motor symptoms (UPDRS-III [MD]: −2.23; 95% CI: −5.00; 0.53), with very low certainty both due to indirectness and significant risk of bias.

Conclusion

With very low to moderate certainty, probiotics, prebiotics, and synbiotics may improve constipation and motor symptoms in PD compared to placebo. These findings suggest a potential benefit, but more high-quality research is needed to confirm these effects and establish stronger evidence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseSynbioticsPrebioticsProbioticsHumansGastrointestinal MicrobiomeDietary SupplementsConstipationRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

AgeingDecision-makingDementiaMetabolismParkinson’s disease

Substanzen

Prebiotics

Autor:innen und Institutionen

  • Grupo de Investigación Neurociencia, Metabolismo, Efectividad Clínica y Salud Pública (NEMECS), Universidad Científica del Sur, Lima, Peru.
  • Facultad de Medicina, Universidad Nacional Mayor de San Marcos, Lima, Peru.
  • Facultad de Medicina, Universidad Nacional San Luis Gonzaga, Ica, Peru.
  • Grupo de Investigación Neurociencia, Metabolismo, Efectividad Clínica y Salud Pública (NEMECS), Universidad Científica del Sur, Lima, Peru, calvad@cientifica.edu.pe.
  • Servicio de Neurología, Departamento de Medicina y Oficina de Apoyo a la Docencia e Investigación (OADI), Hospital Nacional Daniel Alcides Carrion, Callao, Peru, calvad@cientifica.edu.pe.
  • Servicio de Neurología, Departamento de Medicina y Oficina de Apoyo a la Docencia e Investigación (OADI), Hospital Nacional Daniel Alcides Carrion, Callao, Peru.

Zitieren

APA

Cabanillas-Lazo, M., Pascual-Guevara, M., Chavez-Ecos, F. A., Alva-Diaz, C., Velasquez-Rimachi, V., Mori, N., & Micheli, F. (2026). Probiotic, Prebiotic, or Synbiotic Supplementation in Parkinson’s Disease: A Systematic Review and Meta-Analysis with Trial Sequential Analysis. Gerontology, 72(2), 126-141. https://doi.org/10.1159/000547665

Vancouver

Cabanillas-Lazo M, Pascual-Guevara M, Chavez-Ecos FA, Alva-Diaz C, Velasquez-Rimachi V, Mori N, et al. Probiotic, Prebiotic, or Synbiotic Supplementation in Parkinson’s Disease: A Systematic Review and Meta-Analysis with Trial Sequential Analysis. Gerontology. 2026;72(2):126-141. doi:10.1159/000547665

BibTeX
@article{CabanillasLazo2026,
  author = {Cabanillas-Lazo, Miguel and Pascual-Guevara, Milagros and Chavez-Ecos, Fabian A and Alva-Diaz, Carlos and Velasquez-Rimachi, Victor and Mori, Nicanor and Micheli, Federico},
  title = {Probiotic, Prebiotic, or Synbiotic Supplementation in Parkinson’s Disease: A Systematic Review and Meta-Analysis with Trial Sequential Analysis},
  journal = {Gerontology},
  year = {2026},
  volume = {72},
  number = {2},
  pages = {126--141},
  doi = {10.1159/000547665}
}
Kostenlos starten →